News / Marken expansion pushes UPS to forefront of pharma clinical trials sector

Clinical trials specialist and UPS-subsidiary Marken has engaged in a wave of acquisitions to boost its presence in central Europe. 

Its purchases of Austria’s Der Kurier, Hungary’s Heto and Italy’s HRTL appear to support UPS’s ambition to become a market leader in the clinical trials space. 

Marken chief executive Wes Wheeler said: “The acquisition of these companies is an extension of Marken’s growth and satisfies our need for a physical presence in Italy, Austria and Hungary. 

“We will quickly integrate these three new companies into ...